CortheraBio

logo

Core Products

Focus on Developing Undruggable Targets and First-in-Class Innovative Drugs

Cothera Bioscience is focusing on developing therapeutics for previous undruggable oncology targets with high unmet medical needs.  Current pipeline includes three clinical stage programs targeting Myc and KRAS.